Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report

Mahdi M Fadlallah1,2, Darine M Kharroubi1,2, Zeinab Zeineddine1,2

  • 1Department of Laboratory Medicine, Al-Zahraa Hospital University Medical Center, Beirut, LBN.

Cureus
|September 2, 2022
PubMed

Insights

Chryseobacterium indologenes is a rare pathogen causing opportunistic infections. This case highlights successful treatment of Chryseobacterium indologenes pneumonia with ciprofloxacin in Lebanon.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases

Background:

  • Chryseobacterium indologenes is a rare, non-fermenting Gram-negative pathogen.
  • Nosocomial infections caused by this bacterium are increasing, often linked to medical devices.
  • High intrinsic antibiotic resistance poses treatment challenges.

Observation:

  • A 94-year-old female patient intubated for a cerebral vascular accident developed a fever.
  • Tracheal aspirate cultures identified Chryseobacterium indologenes, characterized by yellow-pigmented colonies.
  • Antimicrobial susceptibility testing revealed resistance to most antibiotics but susceptibility to ciprofloxacin, minocycline, and trimethoprim-sulfamethoxazole.

Findings:

  • The patient's Chryseobacterium indologenes infection was successfully treated with ciprofloxacin.
  • This case represents the first reported instance of C. indologenes infection in Lebanon.

Implications:

  • Ciprofloxacin is a viable treatment option for Chryseobacterium indologenes infections.
  • This case underscores the importance of accurate identification and susceptibility testing for rare pathogens.
  • Further research is needed to establish effective treatment protocols for C. indologenes infections.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
397
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
282
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
324
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
305
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
289
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
430